Yes, disappointing to hear expectation of fda clearance now pushed back with no further target date given.
Given the safety and efficacy track record of iTrack and the later iTrack Advance already having clearance and growing sales in Germany it seems likely there are only minor issues to be be addressed.
We will now have to wait patiently, longer, for this clearance but it will come and then when it does we will see an upgrade to our share price
Yes, disappointing to hear expectation of fda clearance now...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.010(3.39%) |
Mkt cap ! $65.21M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.0¢ | 28.0¢ | $180.6K | 627.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 129581 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 266245 | 6 |
View Market Depth
| Last trade - 15.13pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
-0.010 ( 3.06 %) |
||||
| Open | High | Low | Volume | ||
| 30.0¢ | 30.0¢ | 27.5¢ | 427036 | ||
| Last updated 15.55pm 21/05/2024 ? | |||||
| EYE (ASX) Chart |